Background and Purpose-Pial artery dilation in response to activators of the ATP-sensitive K ϩ (K ATP ) and calciumsensitive K ϩ (K Ca ) channels is impaired after fluid percussion brain injury (FPI). Vasopressin, when coadministered with the K ATP and K Ca channel agonists cromakalim and NS1619 in a concentration approximating that observed in cerebrospinal fluid (CSF) after FPI, blunted K ATP and K Ca channel-mediated vasodilation. Vasopressin also contributes to impaired K ATP and K Ca channel vasodilation after FPI. In addition, protein kinase C (PKC) activation generates superoxide anion (O 2 Ϫ ), which in turn contributes to K ATP channel impairment after FPI. We tested whether vasopressin generates O 2 Ϫ in a protein kinase C (PKC)-dependent manner, which could link vasopressin release to impaired K ATP and K Ca channel-induced pial artery dilation after FPI. Methods-Injury of moderate severity (1.9 to 2.1 atm) was produced with the lateral FPI technique in anesthetized newborn pigs equipped with a closed cranial window. Superoxide dismutase-inhibitable nitroblue tetrazolium (NBT) reduction was determined as an index of O 2 Ϫ generation. Results-Under sham injury conditions, topical vasopressin (40 pg/mL, the concentration present in CSF after FPI) increased superoxide dismutase-inhibitable NBT reduction from 1Ϯ1 to 23Ϯ4 pmol/mm 2 . Chelerythrine (10 Ϫ7 mol/L, a PKC inhibitor) blunted such NBT reduction (1Ϯ1 to 9Ϯ2 pmol/mm 2 ), whereas the vasopressin antagonist l-(-mercapto-,-cyclopentamethylene propionic acid)2-(o-methyl)-Tyr-arginine vasopressin (MEAVP) blocked NBT reduction. Chelerythrine and MEAVP also blunted the NBT reduction observed after FPI (1Ϯ1 to 15Ϯ1, 1Ϯ1 to 4Ϯ1, and 1Ϯ1 to 5Ϯ1 pmol/mm 2 for sham-, chelerythrine-, and MEAVP-treated animals, respectively). Under sham injury conditions, vasopressin (40 pg/mL) coadministered with cromakalim or NS1619 blunted dilation in response to these K ϩ channel agonists, whereas chelerythrine partially restored such impaired vasodilation for cromakalim but not NS1619. Cromakalim-and NS1619-induced pial artery dilation also was blunted after FPI. MEAVP partially protected dilation to both K ϩ channel agonists after FPI, whereas chelerythrine did so for only cromakalim responses (for cromakalim at 10 Ϫ8 and 10 Ϫ6 mol/L, 13Ϯ1% and 23Ϯ1%, 2Ϯ1% and 5Ϯ1%, 9Ϯ1% and 15Ϯ2%, and 9Ϯ1% and 16Ϯ2% for sham-, FPI-, FPI-MEAVP-, and FPI-chelerythrine-pretreated animals, respectively). Conclusions-These data show that vasopressin, in concentrations present in CSF after FPI, increased O 2 Ϫ production in a PKC-dependent manner and contributes to such production after FPI. These data show that vasopressin contributes to K ATP but not K Ca channel function impairment in a PKC-dependent manner after FPI and suggest that vasopressin contributes to K Ca channel function impairment after FPI via a mechanism independent of PKC activation. (Stroke.